Target deconvolution strategies in drug discovery

Recognition of some of the limitations of target-based drug discovery has recently led to the renaissance of a more holistic approach in which complex biological systems are investigated for phenotypic changes upon exposure to small molecules. The subsequent identification of the molecular targets that underlie an observed phenotypic response — termed target deconvolution — is an important aspect of current drug discovery, as knowledge of the molecular targets will greatly aid drug development. Here, the broad panel of experimental strategies that can be applied to target deconvolution is critically reviewed.

[1]  P. Cuatrecasas Affinity chromatography and purification of the insulin receptor of liver cell membranes. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Shaltiel [9] Hydrophobic chromatography , 1974 .

[3]  S. Shaltiel Hydrophobic chromatography. , 1974, Methods in enzymology.

[4]  S. Shaltiel [3] Hydrophobic chromatography , 1984 .

[5]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[6]  P. Laing,et al.  Luminescent visualization of antigens on blots. , 1986, Journal of immunological methods.

[7]  D. Mccormick Sequence the Human Genome , 1986, Bio/Technology.

[8]  Nolan H. Sigal,et al.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin , 1989, Nature.

[9]  S. Fields,et al.  A novel genetic system to detect protein–protein interactions , 1989, Nature.

[10]  S. Schreiber,et al.  A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase , 1989, Nature.

[11]  W. Dower,et al.  An in vitro polysome display system for identifying ligands from very large peptide libraries. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Y. Clonis,et al.  The affinity technology in downstream processing. , 1994, Journal of biotechnology.

[13]  S. Schreiber,et al.  A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p , 1996, Science.

[14]  E J Licitra,et al.  A three-hybrid system for detecting small ligand-protein receptor interactions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  C. Ampe,et al.  A Phage Display Technique for a Fast, Sensitive, and Systematic Investigation of Protein–Protein Interactions , 1997, Journal of protein chemistry.

[16]  S H Kim,et al.  Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.

[17]  J. Yates Mass spectrometry and the age of the proteome. , 1998, Journal of mass spectrometry : JMS.

[18]  Georg C. Terstappen,et al.  High Throughput Scintillation Proximity Assay for the Identification of FKBP-12 Ligands , 1999, Journal of biomolecular screening.

[19]  D. Austin,et al.  Display cloning: functional identification of natural product receptors using cDNA-phage display. , 1999, Chemistry & biology.

[20]  H. Handa,et al.  High-performance affinity beads for identifying drug receptors , 2000, Nature Biotechnology.

[21]  J Mottram,et al.  Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. , 2000, Chemistry & biology.

[22]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[23]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[24]  D. Sabatini,et al.  Microarrays of cells expressing defined cDNAs , 2001, Nature.

[25]  M. Wright,et al.  In Vitro Selection and Characterization of Bcl-XL-binding Proteins from a Mix of Tissue-specific mRNA Display Libraries* , 2001, The Journal of Biological Chemistry.

[26]  Timothy A J Haystead,et al.  Discovery of novel targets of quinoline drugs in the human purine binding proteome. , 2002, Molecular pharmacology.

[27]  B. Kreider,et al.  Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. , 2002, Chemistry & biology.

[28]  J. Kuriyan,et al.  Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. , 2002, Cancer research.

[29]  John Kuriyan,et al.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). , 2001, Cancer research.

[30]  K. Fitzgerald,et al.  Model Organisms in Drug Discovery , 2003 .

[31]  R. Strausberg,et al.  From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes , 2003, Science.

[32]  A. Jungbauer,et al.  Directed immobilization of peptide ligands to accessible pore sites by conjugation with a placeholder molecule. , 2003, Analytical chemistry.

[33]  M. Cotten,et al.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Snyder,et al.  Protein chip technology. , 2003, Current opinion in chemical biology.

[35]  Michael N. Hall,et al.  TOR signalling in bugs, brain and brawn , 2003, Nature Reviews Molecular Cell Biology.

[36]  Yoshiya Oda,et al.  Quantitative chemical proteomics for identifying candidate drug targets. , 2003, Analytical chemistry.

[37]  T. Mayer,et al.  Chemical genetics: tailoring tools for cell biology. , 2003, Trends in cell biology.

[38]  Keiryn L. Bennett,et al.  Analysis of large-scale MS data sets: the dramas and the delights , 2004 .

[39]  E. Brown,et al.  Multicopy suppressors for novel antibacterial compounds reveal targets and drug efflux susceptibility. , 2004, Chemistry & biology.

[40]  C. Nguyên,et al.  A small molecule inhibitor of -cateninCREB-binding protein transcription , 2004 .

[41]  Dalia Cohen,et al.  Functional genomics to new drug targets , 2004, Nature Reviews Drug Discovery.

[42]  Michael I. Jordan,et al.  Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  E. Lander,et al.  Finishing the euchromatic sequence of the human genome , 2004 .

[44]  Janet M Thornton,et al.  Ligand selectivity and competition between enzymes in silico , 2004, Nature Biotechnology.

[45]  T. Terada,et al.  Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins. , 2004, Bioorganic & medicinal chemistry.

[46]  E. Aronica,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.

[47]  J. Bonfield,et al.  Finishing the euchromatic sequence of the human genome , 2004, Nature.

[48]  Hong Ma,et al.  A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Paul A Clemons,et al.  Complex phenotypic assays in high-throughput screening. , 2004, Current opinion in chemical biology.

[50]  Sebastian Meier-Ewert,et al.  A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors. , 2004, Chemistry & biology.

[51]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[52]  S. Haggarty,et al.  Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chips. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  So-Jung Park,et al.  A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function. , 2004, Chemistry & biology.

[54]  Peter G Schultz,et al.  A genome-wide overexpression screen in yeast for small-molecule target identification. , 2005, Chemistry & biology.

[55]  E. Butcher Can cell systems biology rescue drug discovery? , 2005, Nature Reviews Drug Discovery.

[56]  F. Sams-Dodd Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[57]  Andreas Kremer,et al.  A Bioinformatics Perspective on Proteomics: Data Storage, Analysis, and Integration , 2005, Bioscience reports.

[58]  Walter Sneader,et al.  Drug Discovery (The History) , 2005 .

[59]  Lin Tang,et al.  Roscovitine Targets, Protein Kinases and Pyridoxal Kinase*[boxs] , 2005, Journal of Biological Chemistry.

[60]  Young-Tae Chang,et al.  Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. , 2005, Chemistry & biology.

[61]  A. Manolis,et al.  Rethinking target discovery in polygenic diseases. , 2006, Current topics in medicinal chemistry.

[62]  Eugene W Gerner,et al.  Pharmacogenomics of the Polyamine Analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl] eicosane Tetrahydrochloride, CGC-11093, in the Colon Adenocarcinoma Cell Line HCT1161 , 2006, Technology in cancer research & treatment.

[63]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[64]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[65]  K. Yeow,et al.  Cellular imaging in drug discovery , 2006, Nature Reviews Drug Discovery.

[66]  Jan Tavernier,et al.  MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells. , 2006, Chemistry & biology.

[67]  A. Tanaka,et al.  A versatile method of identifying specific binding proteins on affinity resins. , 2006, Analytical biochemistry.

[68]  M. Kirschner,et al.  Biochemical suppression of small-molecule inhibitors: a strategy to identify inhibitor targets and signaling pathway components. , 2006, Chemistry & biology.

[69]  P. Schultz,et al.  Small-molecule synergist of the Wnt/β-catenin signaling pathway , 2007, Proceedings of the National Academy of Sciences.

[70]  B. Stockwell,et al.  Chemical genetic approaches to probing cell death. , 2007, Current opinion in chemical biology.

[71]  Sean Ekins,et al.  Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.

[72]  A. Sickmann,et al.  Protein identification using mass spectrometry: a method overview. , 2007, EXS.

[73]  G. Jiang,et al.  Preparation of a biochip on porous silicon and application for label-free detection of small molecule-protein interactions. , 2007, Rapid communications in mass spectrometry : RCM.

[74]  L. Meijer,et al.  Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatography , 2007, Biotechnology journal.

[75]  M. Uesugi,et al.  Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin. , 2007, Journal of the American Chemical Society.

[76]  Eduardo Gonzalez-Couto,et al.  Huntington's disease: from experimental results to interaction networks, patho-pathway construction and disease hypothesis , 2007, BMC Systems Biology.

[77]  A. Tanaka [A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[78]  Hans Clevers,et al.  Mining the Wnt pathway for cancer therapeutics , 2007, Nature Reviews Drug Discovery.

[79]  Xiaodong Wang,et al.  Diazonamide toxins reveal an unexpected function for ornithine δ-amino transferase in mitotic cell division , 2007, Proceedings of the National Academy of Sciences.

[80]  Lennart Martens,et al.  Annotating the human proteome: beyond establishing a parts list. , 2007, Biochimica et biophysica acta.